Wolff-Parkinson-White (WPW) Syndrome
Wolff-Parkinson-White syndrome is a congenital cardiac condition characterized by the presence of an accessory electrical pathway between the atria and ventricles that bypasses the normal AV nodal conduction system, resulting in ventricular pre-excitation and increased risk of tachyarrhythmias and sudden cardiac death. 1, 2
Definition and Electrocardiographic Features
WPW syndrome is defined by:
- Specific ECG pattern (WPW pattern) showing:
- Short PR interval (<120 ms)
- Delta wave (slurring of the initial QRS upstroke)
- Widened QRS complex (>120 ms)
- Presence of symptomatic tachyarrhythmias 2
The prevalence of WPW pattern on ECG ranges from 0.1% to 0.3% in the general population 1, 2.
Pathophysiology
WPW syndrome results from:
- Abnormal accessory pathway (AP) connecting atria and ventricles
- Bypass of the normal AV nodal delay
- Creation of a potential reentry circuit that can sustain tachyarrhythmias 2
Types of accessory pathways include:
- Manifest pathways (conduct antegrade, visible on ECG)
- Concealed pathways (conduct only retrograde, not visible on resting ECG)
- Decremental pathways (slow conducting, like PJRT) 1, 2
Clinical Manifestations and Associated Arrhythmias
Common arrhythmias in WPW syndrome:
Orthodromic AVRT (95% of cases):
- Antegrade conduction through AV node
- Retrograde conduction through accessory pathway
- Presents as narrow QRS tachycardia 2
Antidromic AVRT (less common):
- Antegrade conduction through accessory pathway
- Retrograde conduction through AV node
- Presents as wide QRS tachycardia 2
Atrial Fibrillation (AF):
Permanent Junctional Reciprocating Tachycardia (PJRT):
Risk Stratification
High-risk features for sudden cardiac death:
- Shortest pre-excited R-R interval <250 ms during atrial fibrillation
- History of symptomatic tachycardia
- Multiple accessory pathways
- Posteroseptally located pathways 1, 2
The 10-year risk of sudden cardiac death ranges from 0.15% to 0.24% in patients with WPW 1. The risk appears highest in the first two decades of life 1.
Low-risk features:
- Intermittent pre-excitation
- Abrupt loss of pre-excitation during exercise
- Loss of pre-excitation after drug administration (ajmaline, procainamide) 1, 2
Acute Management
For orthodromic AVRT:
- Vagal maneuvers (first-line) 1
- Adenosine (if vagal maneuvers fail) 1
- Synchronized cardioversion for hemodynamically unstable patients 1
For pre-excited atrial fibrillation:
- Immediate synchronized cardioversion for hemodynamically unstable patients 1
- Ibutilide or IV procainamide for hemodynamically stable patients 1
CAUTION: AV nodal blocking agents (calcium channel blockers, beta-blockers, digoxin) should be avoided in pre-excited AF as they can enhance conduction through the accessory pathway and potentially precipitate ventricular fibrillation 2.
Definitive Management
Catheter ablation is the first-line definitive treatment for symptomatic WPW syndrome, with success rates exceeding 95% and complication rates of 1-2% in experienced centers. 1, 2
Indications for catheter ablation:
- Symptomatic tachyarrhythmias
- Documented atrial fibrillation with rapid ventricular response
- Survivors of ventricular fibrillation
- High-risk occupations (pilots, athletes, heavy machinery operators) 1, 2
For asymptomatic patients with incidental WPW pattern:
- Risk stratification should guide management
- Catheter ablation may be considered in high-risk professions or athletes
- Observation may be appropriate for truly low-risk patients 1, 2
Special Considerations
In athletes:
- Comprehensive risk evaluation before competitive sports participation
- Catheter ablation recommended for symptomatic athletes or those with high-risk features 1
Associated conditions:
- Ebstein's anomaly
- Hypertrophic cardiomyopathy
- Other structural heart diseases 2
Prognosis
With appropriate management:
- Excellent prognosis following successful ablation
- Normal life expectancy
- Low recurrence rate (5-10%) after ablation 2
Most asymptomatic patients with WPW pattern have a good prognosis, but sudden cardiac death can be the first manifestation of the disease in some cases 1.